Recombinant Rhesus monkey MAT2B Protein, His-tagged

• Cat.No.: MAT2B-2686R
• Product Overview: Recombinant Rhesus monkey MAT2B full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Rhesus monkey
• Tag: His
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: MAT2B methionine adenosyltransferase II, beta [ Macaca mulatta (Rhesus monkey) ]
• Official Symbol: MAT2B
• Synonyms: MAT2B; methionine adenosyltransferase 2 subunit beta
• Gene ID: 698119
• mRNA Refseq: NM_001257473
• Protein Refseq: NP_001244402
• UniProt ID: F6RZ93

Reviews

06/24/2021

The MAT2B Protein exhibits remarkable stability and functionality, making it an optimal choice for a wide range of applications in various fields.

08/29/2020

Their prompt and knowledgeable assistance has been instrumental in overcoming hurdles and has significantly contributed to the success of my research.

11/08/2018

Its exceptional purity and consistency have consistently yielded reliable and reproducible results, ensuring the accuracy and reliability of my research outcomes.

Q&As

How does MAT2B affect cell proliferation and growth?

MAT2B's involvement in SAMe production influences pathways related to cell growth, potentially impacting proliferation in various tissues.

How does MAT2B contribute to cellular function?

MAT2B forms a complex with MAT2A, enhancing the activity of MAT2A in synthesizing SAMe, a crucial methyl donor in numerous biochemical reactions.

Can MAT2B expression be altered in cancer?

Yes, changes in MAT2B expression have been observed in different cancers, indicating its potential as a diagnostic or therapeutic target.

Can MAT2B be used as a diagnostic marker?

While research shows associations between MAT2B expression and certain diseases, it's not currently employed as a diagnostic marker in clinical settings.

Are there any ongoing clinical trials involving MAT2B?

As of my last update, specific clinical trials targeting MAT2B in disease management were not widespread, but research in this area is ongoing.